Gliclazide (JAN) en es it fr

Gliclazide (JAN) Brand names, Gliclazide (JAN) Analogs

Gliclazide (JAN) Brand Names Mixture

  • No information avaliable

Gliclazide (JAN) Chemical_Formula


Gliclazide (JAN) RX_link

No information avaliable

Gliclazide (JAN) fda sheet

Gliclazide (JAN) msds (material safety sheet)

Gliclazide_(JAN) MSDS

Gliclazide (JAN) Synthesis Reference

No information avaliable

Gliclazide (JAN) Molecular Weight

323.412 g/mol

Gliclazide (JAN) Melting Point

181 oC

Gliclazide (JAN) H2O Solubility

No information avaliable

Gliclazide (JAN) State


Gliclazide (JAN) LogP


Gliclazide (JAN) Dosage Forms


Gliclazide (JAN) Indication

For the treatment of Diabetes mellitus

Gliclazide (JAN) Pharmacology

Gliclazide is a second generation sulphonylurea which acts as a hypoglycemic agent. It stimulates beta cells of the islet of Langerhans in the pancreas to release insulin. It also enhances peripheral insulin sensitivity. Overall it potentiates insulin release and improves insulin dynamics.

Gliclazide (JAN) Absorption

Rapidly and well absorbed but may have wide inter- and intra-individual variability.

Gliclazide (JAN) side effects and Toxicity

LD50=3000 mg/kg (orally in mice)

Gliclazide (JAN) Patient Information

No information avaliable

Gliclazide (JAN) Organisms Affected

Humans and other mammals